University Center for Tumor Diseases

What University Center for Tumor Diseases does

The University Center for Tumor Diseases (UCT Frankfurt) is a comprehensive interdisciplinary cancer center jointly operated by the Faculty of Medicine of Goethe University Frankfurt, the Georg-Speyer-Haus research institute, Universitätsklinikum Frankfurt, and Krankenhaus Nordwest. It functions as the coordinating umbrella for eight Deutsche Krebsgesellschaft (DKG)-certified organ cancer centers covering breast, gynecological, skin, head and neck, lung, neuro-oncology, uro-oncology, and visceral oncology — supplemented by a Center for Personalized Medicine in Oncology (ZPM-O), a Familial Breast and Ovarian Cancer Center (FBREK), a survivorship program, and a broad supportive-care layer including psycho-oncology, palliative medicine, art therapy, and sports therapy. The center operates two physical sites in Frankfurt (Theodor-Stern-Kai 7 and Steinbacher Hohl 2-26) and runs a Molecular Tumor Board, a UCT Biobank, a José Carreras Phase I/II early clinical trial unit, and Study Navigator ("Studienlotsen") services that route advanced-cancer patients into clinical trials.

UCT Frankfurt's core technology stack centers on precision oncology: comprehensive molecular profiling through next-generation sequencing, single-gene analysis, fragment length analysis, PCR variants, and hybridization techniques (FISH, SISH), combined with AI-assisted digital whole-body dermatoscopy for skin cancer screening and predictive analytics for prognostic/predictive biomarkers. A Clinical and Real World Data platform linked to the UCT Biobank creates a longitudinal data asset for translational research and quality benchmarking. The infrastructure is wired into national networks including DKTK (German Cancer Consortium), nNGM (National Network Genomic Medicine Lung Cancer), and DNPM (German Network for Personalized Medicine), enabling cross-center trial access and standardized molecular workflows.

The business model operates within the German public healthcare and academic system. Revenue is generated through statutory health insurance (GKV) reimbursement under the DRG system, private health insurance billing, designated research funding from Deutsche Krebshilfe (as one of 14 Oncological Centers of Excellence) and DKTK, and charitable donations supporting patient-experience services and research. As a public, university-affiliated institution, UCT Frankfurt does not raise venture or growth-equity capital; governance is collaborative across the partner institutions through a directorium (board) structure. Services are delivered directly through the two hospital campuses and indirectly via the regional Hessisches Onkologiekonzept referral network spanning Frankfurt-Offenbach and the Rhine-Main region.

Name

University Center for Tumor Diseases

Legal name

Universitäres Centrum für Tumorerkrankungen Frankfurt (UCT Frankfurt)

Website

https://uct-frankfurt.de

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

UCT Frankfurt is a German public comprehensive cancer center jointly operated by Goethe University Frankfurt, Georg-Speyer-Haus, Universitätsklinikum Frankfurt, and Krankenhaus Nordwest. It delivers interdisciplinary cancer care across eight DKG-certified organ centers, molecular diagnostics, early-phase clinical trials, and personalized oncology across the Rhine-Main region.

Ownership category

akta.pro rank

Product category

Comprehensive Cancer Treatment Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (62211), Medical Laboratories (621511), Other Outpatient Care Centers (62149)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Oncology treatment services
• Cancer care centers
• Precision oncology
• Molecular diagnostics
• Clinical cancer research

Headquarters

HQ city

Frankfurt

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Statutory Health Insurance (GKV) Reimbursement: As a German university hospital cancer center, UCT operates within the German healthcare system where services are reimbursed through statutory health insurance funds. Treatment costs are covered through the standard DRG (Diagnosis-Related Groups) system and oncological care contracts with health insurance providers.
2. Private Health Insurance Reimbursement: Services provided to privately insured patients are billed through private health insurance schemes.
3. Research Funding and Grants: Funding from Deutsche Krebshilfe as recognized Oncological Center of Excellence, DKTK (German Cancer Consortium), and other research grants support research activities and infrastructure.
4. Donations: Charitable donations support patient treatment beyond standard care, palliative medicine, psycho-oncology, sports therapy, cancer research, and education of young professionals.

Distribution channels5 records

Marketing channels5 records

Core offering

UCT Frankfurt is a university cancer center that delivers interdisciplinary diagnosis, treatment, and research across all major tumor types through nine DKG-certified organ cancer centers and two specialized centers. It combines molecular diagnostics, personalized oncology, Phase I/II clinical trials, robotic surgery, and comprehensive supportive care (psycho-oncology, palliative medicine, nutritional counseling, sports therapy) at two hospital locations in Frankfurt. The center integrates translational cancer research from bench to bedside via the Molecular Tumor Board, UCT Biobank, and partnership with Goethe University Frankfurt.

Product overview

The University Cancer Center (UCT) Frankfurt is a comprehensive oncology center operating as a network of specialized organ cancer centers and supportive care services. It functions as an integrated healthcare platform combining eight DKG-certified organ cancer centers (breast, gynecological, skin, head/neck, lung, neuro-oncology, uro-oncology, and visceral oncology), a Center for Personalized Medicine offering molecular diagnostics and targeted therapies, a Family Cancer Center for hereditary cancers, and comprehensive supportive services including psycho-oncology, nutritional counseling, palliative care, and social services. The center also maintains active clinical trial programs and study navigation services, all coordinated through interdisciplinary tumor boards and the Molecular Tumor Board for personalized treatment recommendations.

Differentiator

Problem solved

Functional benefit

Brands

• Brustzentrum: Breast Cancer Center providing specialized diagnosis and treatment for breast diseases
• Gynäkologisches Krebszentrum
• Hautkrebszentrum
• Kopf-Hals-Tumorzentrum
• Lungenkrebszentrum
• Neuroonkologisches Zentrum
• Uroonkologisches Zentrum
• Viszeralonkologisches Zentrum
• ZPM-O (Zentrum für Personalisierte Medizin für Onkologie)
• FBREK (Zentrum für familiären Brust- und Eierstockkrebs)
• Studienlotsen

Products and services

• Brustzentrum (Breast Cancer Center) Certified center specializing in diagnosis and treatment of breast diseases, particularly breast cancer, offering comprehensive care including modern diagnostics, oncological treatment, breast surgery with oncoplastic techniques, and reconstruction options.
• Gynäkologisches Krebszentrum (Gynecological Cancer Center) Deutsche Krebsgesellschaft-certified center treating all cancers of female reproductive organs including ovarian, cervical, endometrial, vulvar, and vaginal cancers, with expertise in immunotherapy, targeted therapy, and fertility preservation in collaboration with FertiPROTEKT.
• Hautkrebszentrum (Skin Cancer Center) Certified center for comprehensive skin cancer treatment including melanoma, basal cell carcinoma, and cutaneous squamous cell carcinoma, offering surgery, immunotherapy, targeted therapy, and AI-assisted diagnostics via digital whole-body dermatoscopy.
• Kopf-Hals-Tumorzentrum (Head and Neck Tumor Center) Center treating tumors of the head and neck region including nose, sinuses, throat, larynx, oral cavity, salivary glands, and facial bones, offering minimally invasive laser surgery, 3D reconstruction, and innovative drug therapies.
• Lungenkrebszentrum (Lung Cancer Center) Deutsche Krebsgesellschaft-certified center offering comprehensive lung cancer care including advanced diagnostics, robotic surgery (DaVinci), radiation therapy, chemotherapy, immunotherapy, and targeted therapies, as well as access to clinical trials.
• Neuroonkologisches Zentrum (Neuro-Oncology Center) The only DKG-certified brain tumor center in Frankfurt, offering multidisciplinary diagnosis and therapy including CAR-T cell therapy (CAR2BRAIN study), modern personalized treatments, and access to innovative clinical trials.
• Uroonkologisches Zentrum (Uro-Oncology Center) Certified center treating urological cancers including prostate, bladder, and kidney cancer using the latest generation Da Vinci robotic surgical system for minimally invasive procedures with highest precision.
• Viszeralonkologisches Zentrum (Visceral Oncology Center) Center treating abdominal organ tumors including esophageal, thyroid, stomach, liver, gallbladder, pancreatic, intestinal, and neuroendocrine tumors, housing four DKG-certified organ cancer centers (colorectal, pancreatic, gastric, liver).
• Zentrum für Personalisierte Medizin für Onkologie (ZPM-O) DKG-certified center performing comprehensive molecular diagnostics including next-generation sequencing to identify genetic tumor profiles, with a weekly Molecular Tumor Board recommending targeted therapies based on individual molecular characteristics.
• Zentrum für familiären Brust- und Eierstockkrebs (FBREK) Certified family cancer center providing genetic counseling, risk assessment, and preventive care for patients with familial breast and ovarian cancer risk, affiliated with the BRCA Network.
• Langzeitnachsorge (Long-term Survivorship Care) Comprehensive follow-up care program for cancer survivors who completed treatment, focusing on early detection and management of late effects, psycho-oncological support, and transition to outpatient care.
• Unterstützende Angebote (Supportive Care Services) Comprehensive supportive services including psycho-oncology, nutritional counseling, palliative medicine, social services, art therapy, sports therapy, oncology nursing counseling, and pastoral care, available at no cost to patients.
• Klinische Studien und Studienlotsen (Clinical Trials and Study Navigators) Clinical trial program with study navigators who assist patients in accessing experimental treatments, providing access to innovative therapies and cutting-edge research treatments including Phase I/II trials.

Quantifiable outcome

• Up to 80% long-term survival for childhood and young adult cancer patients
• +3 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• UCT Frankfurt-MarburgcoreStrategic or Co-development PartnerComprehensive cancer center network combining Universitätsmedizin Frankfurt, Krankenhaus Nordwest, and Universitätsklinikum Marburg. Recognized as one of 14 Oncological Centers of Excellence in Germany by Deutsche Krebshilfe. The network coordinates patient care, research, and education across the Rhine-Main and Marburg regions.
• Frankfurt Cancer Institute (FCI)coreStrategic or Co-development PartnerResearch alliance within the UCT structure combining expertise in basic and translational cancer research with clinical care. Part of the precision oncology mission connecting science to patients.
• German Cancer Consortium (DKTK) - Partner Site Frankfurt/MainzcoreStrategic or Co-development PartnerNational research consortium focused on translating molecular information into novel cancer therapies. UCT Frankfurt serves as a partner site contributing to and benefiting from shared research infrastructure and clinical trial networks.
• National Network Genomic Medicine Lung Cancer (nNGM)coreStrategic or Co-development PartnerNationwide network providing advanced lung cancer patients access to molecular diagnostics and innovative targeted therapies. UCT Frankfurt is one of 26 network centers enabling standardized access to personalized medicine.
• German Network for Personalized Medicine (DNPM)coreStrategic or Co-development PartnerCooperation of 26 university hospitals in Germany dedicated to improving cancer care and quality of life for patients with advanced or rare cancers through unified access to personalized medicine approaches.
• Goethe University Frankfurt (Faculty of Medicine)coreStrategic or Co-development PartnerAcademic partner providing research infrastructure, clinical trial capabilities, and educational programs. The translational research framework combines faculty expertise with clinical practice.
• Georg-Speyer-HauscoreStrategic or Co-development PartnerResearch institute specializing in tumor biology and cancer research, contributing to the translational research mission of UCT through basic science expertise.
• FertiPROTEKTminorStrategic or Co-development PartnerGerman network for fertility preservation, collaborating with UCT's Gynecological Cancer Center to provide fertility counseling and preservation options for young women before cancer treatment.
• Hessisches Onkologiekonzept (HOK)coreStrategic or Co-development PartnerRegional oncology concept network coordinating care across Hesse, including coordinating hospitals, cooperating hospitals, specialist practices, and working groups to ensure comprehensive cancer care coverage.
• Self-Help Groups and Patient OrganizationsminorOthersNetwork of over 25 self-help groups and patient organizations (including BRCA-Netzwerk, Frauenselbsthilfe Krebs, Leukämiehilfe Rhein-Main, Deutsche ILCO, and others) providing peer support and patient advocacy.
• Deutsche Krebsgesellschaft (German Cancer Society)coreOthersProfessional oncology society providing certification, quality standards, and recognition for multiple UCT cancer centers through systematic quality assurance programs.

Scale indicators4 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• University Cancer Center Leipzig (UCCL): UCCL at Universitätsklinikum Leipzig is a Deutsche Krebshilfe-designated comprehensive cancer center with multiple DKG-certified organ centers, molecular diagnostics, and translational research—directly comparable to UCT Frankfurt's structure.
• University Cancer Center Hamburg (UCCH): UCCH at Universitätsklinikum Hamburg-Eppendorf is a German excellence cancer center combining organ-specialty centers, molecular diagnostics, and clinical trials. It is structurally and operationally comparable to UCT Frankfurt.
• Charité Comprehensive Cancer Center: Charité's CCCC in Berlin is a German university hospital-based comprehensive cancer center with multiple organ centers, molecular tumor boards, and clinical trials. Like UCT Frankfurt, it holds Deutsche Krebshilfe 'Oncological Center of Excellence' status and operates within a public university hospital structure.
• University Cancer Center Düsseldorf (UTBD): UTBD at Universitätsklinikum Düsseldorf is another German comprehensive cancer center with DKG certifications and translational research programs, operating within a public university hospital setting comparable to UCT Frankfurt.
• National Center for Tumor Diseases (NCT) WERA: NCT WERA is a multi-site German comprehensive cancer center spanning Würzburg, Erlangen, Regensburg, and Augsburg. Comparable to UCT Frankfurt in offering DKG-certified organ centers, molecular tumor boards, and clinical trial infrastructure across university hospitals.
• National Center for Tumor Diseases (NCT) Heidelberg: NCT Heidelberg is one of Germany's leading translational oncology centers jointly run by DKFZ and Heidelberg University Hospital. It shares UCT's bedside-to-bench precision oncology model, DKG certifications, and excellence-center funding structure.
• West German Cancer Center (WTZ): WTZ is the joint oncology center of Universitätsmedizin Essen and Münster, designated as a Deutsche Krebshilfe excellence center. Comparable to UCT in offering multi-organ oncology programs, molecular tumor boards, and Phase I/II trial infrastructure.
• Comprehensive Cancer Center Munich (CCCM): CCCM, jointly run by LMU and TUM university hospitals, is another Deutsche Krebshilfe 'Oncological Center of Excellence.' It mirrors UCT's structure as a multi-site academic comprehensive cancer center with organ-specialty centers and translational research programs.

Regional players

• Sana Klinikum Offenbach: Sana Klinikum Offenbach is a regional hospital in the Rhein-Main area that provides oncology services. It overlaps geographically with UCT Frankfurt's catchment area, competing for some patient referrals in the same metropolitan market.

Broad incumbents

• Asklepios Tumorzentrum Hamburg: Asklepios operates large German hospital networks with oncology programs. While not a single comprehensive cancer center, Asklepios represents the broader private hospital incumbent competing for cancer patients across multiple regions, including areas where UCT-style centers operate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Center for Tumor Diseases